Combination Therapy Study for Acromegaly

This is a 12 month study. During the first 6 months, patients receive combination therapy (Somatostatin Analog + Pegvisomant) and during the second 6 months, they are on Pegvisomant only.

Somatostatin analogs and Pegvisomant lower GH (Growth Hormone), by two very different mechanisms. In this study, we are investigating, the most effective way to combine these drugs, in order to determine the combination that has maximum efficacy, least side-effects, and is most cost-effective.

The study is being performed at Cedars Sinai Medical Center in Los Angeles. Participants will be required to travel to Cedars Sinai Medical Center in Los Angeles 3 times over the 12 month study period (at the study initiation, middle(6 months) and end of the study(12 months). All travel/accommodation costs for the visits are covered by the study. Monthly blood tests will be done at a local quest lab in the patient’s hometown.  Pegvisomant will be shipped to the patient’s home and dose adjustments will be made, depending on the blood test results.

Visits, monthly blood tests, drug dose adjustments and drug shipment will be coordinated by physicians and research staff at Cedars Sinai Medical Center.

To participate in the Combo Study, please email This email address is being protected from spambots. You need JavaScript enabled to view it..


Radiation Options

Radiation Therapy

Radiation therapy is usually reserved for people who have some tumor remaining after surgery and do not respond to medications. Because radiation leads to a slow lowering of GH and IGF-I levels, these patients often also receive medication to lower hormone levels. The full effect of this therapy may not occur for many years.

The two types of radiation delivery are conventional and stereotactic. Conventional radiation delivery targets the tumor with external beams but can damage surrounding tissue. The treatment delivers small doses of radiation multiple times over 4 to 6 weeks, giving normal tissue time to heal between treatments. Stereotactic delivery allows precise targeting of a high-dose beam of radiation at the tumor from varying angles. The patient must wear a rigid head frame to keep the head still. The types of stereotactic radiation delivery currently available are proton beam, linear accelerator (LINAC), and gamma knife. With stereotactic delivery, the tumor must be at least 5 mm from the optic chiasm to prevent radiation damage. This treatment can sometimes be done in a single session, reducing the risk of damage to surrounding tissue.

All forms of radiation therapy cause a gradual decline in production of other pituitary hormones over time, resulting in the need for hormone replacement in most patients. Radiation also can impair a patient's fertility. Vision loss and brain injury are rare complications. Rarely, secondary tumors can develop many years later in areas that were in the path of the radiation beam.

Center for Image-Guided Neurosurgery

Gamma Knife:

Gamma Knife surgery represents one of the most advanced means available to manage brain tumors; arteriovenous malformations and pain or movement disorders. The procedure is unique because, with the Gamma Knife, no surgical incision is performed to expose the target.

The Gamma Knife can destroy deep-seated blood vessel malformations in the head and brain tumors once considered inoperable. It can also eliminate pain conditions and certain movement disorders, as well as silence malfunctioning areas of the brain precisely, to stop seizures or ease disabling pain problems that have not responded to other management strategies.

The Center for Image-Guided Neurosurgery at the University of Pittsburgh Medical Center installed the first North American Gamma Knife in 1987 and subsequently introduced and pioneered each succeeding generation of technological improvement. Staffed by a highly skilled and productive team, we seek to provide rapid screening, scheduling, and completion of Gamma Knife radiosurgical procedures.

During UPMC's first 20 years of experience, more than 8,500 patients have undergone radiosurgery in the department's Gamma Knife units. In May of 2004 our center added a third Gamma Knife unit, becoming the only center in the world with three operating units. In September of 2007, the new Perfexion® Gamma Knife unit -- encompassing the latest advances in radiosurgical technology -- was installed.

The Gamma Knife Unit

The Gamma Knife contains up to 201 cobalt-60 sources of approximately 30 curies each, placed in a circular array in a heavily shielded unit. The unit directs gamma radiation to a target point. Such target points selected in the brain can be placed at the center of the radiation focus, allowing a tumoricidal radiation dosage to be delivered in one treatment session. The Gamma Knife has proved effective for thousands of patients with benign or malignant brain tumors, vascular malformations, pain or other functional problems.

Continue reading


Surgery Frequently Asked Questions

About Transsphenoidal Surgery For Pituitary Adenomas: A Patient Guide: /TranssphenoidalSurgery.htm
by Brooke Swearingen, M.D. (In Bulletin Volume 8, Issue 1, Fall/Winter 2002)

I have been told I need surgery for a pituitary adenoma. What does this mean?

Pituitary adenomas are benign tumors which arise from the pituitary gland itself. They are almost never malignant. Pituitary tumors can be either secretory or non-secretory, referring to whether they overproduce pituitary hormones. Secretory tumors cause disease because of the excess quantities of hormones which they secrete (release) into the bloodstream. The most common type of secretory pituitary tumor is termed a prolactinoma. Excess prolactin in the blood may lead to irregular or absent periods in women, decreased libido and erections in men and infertility or milk production in men or women. However, there are excellent medicines available to treat this disorder, so surgery is rarely needed. Most patients with prolactinomas are treated by endocrinologists, who are medical specialists in gland and hormone disorders. Secretory tumors, which commonly require surgery, include those which cause acromegaly and Cushing's disease. Acromegaly (or gigantism if occurring in a child) results from an excess of growth hormone production. Too much adrenocorticotropic hormone (ACTH) leads to overproduction of cortisol by the adrenal glands, giving rise to a disorder called Cushing's disease. Surgical removal of these tumors can restore normal hormone production in many cases. Non-secretory tumors (which are also termed "non-functioning") do not overproduce hormones, but cause problems due to their size and location. This is because they can compress both the normal pituitary gland and the surrounding structures. Hormone deficiencies may result from compression of the normal pituitary gland. Non-secreting tumors can also cause vision problems by growing upwards and compressing the optic nerves and chiasm, nerves which are important for vision. This pressure can lead to loss of peripheral vision. Surgery can remove such tumors and relieve the pressure on surrounding structures

How is this surgery performed?

Most pituitary tumors can be removed transsphenoidally. The approach is through the sphenoid sinus, one of the facial air spaces behind the nose. Rarely, a craniotomy is required, where the skull is opened to reach the tumor. There are three basic approaches to the sella, which is the bony cavity in the skull base where the pituitary gland is located. Many neurosurgeons now use a direct transnasal approach, where an incision is made in the back wall of the nose and the sphenoid sinus is entered directly. It is also possible to make an incision along the front of the nasal septum, and make a tunnel back to the sphenoid sinus. Finally, it is possible to make an incision under the lip and approach through the upper gum, and enter the nasal cavity and then the sphenoid sinus.

How do you see the tumor?

The opening through which transsphenoidal surgery is performed is very small, about ½ an inch. Therefore, it is not possible to look with unaided vision at the surgical area or tumor. However, modern technology has developed tools for visualizing the area of the tumor through the small hole. This is done by using a high powered operating microscope, or a fiberoptic endoscope. The operating microscope allows binocular vision with extremely high quality optics. This is very important for tiny tumors, like those responsible for Cushing's disease. The endoscope provides a wider field of view, but usually with monocular images as seen on a television screen. At the Massachusetts General Hospital, a direct transnasal approach is used, whether we use the microscope or the endoscope, or both. With the direct transnasal approach, the need for postoperative nasal packing (bandaging in the nose) is minimized, regardless of whether the microscope or endoscope is used.

How is the tumor removed?

The tumor is usually soft and can be removed with small surgical instruments called curettes. In order to remove a large tumor through a small hole, the tumor itself has to be cut into small pieces. As the surgeon cores out the center of the tumor, the peripheral margin of the tumor has to fall into an area that can be reached by the surgeon. Some tumors, which have grown beyond the area of the sella, cannot be completely removed. Tumors that grow sideways into the cavernous sinus, a collection of veins next to the sella, usually cannot be completely removed. This is because that area contains important nerves controlling muscles of the eye and the carotid artery, which supplies the brain. Tumors which have a large amount of supra-sellar extension (up into the brain) can be removed in one operation if they fall downward into the sella during the procedure. Sometimes the removal of large tumors has to be staged into two operations, to allow time for the uppermost portion of the tumor to fall into the sella where it can be reached on a subsequent operation.

Do all pituitary tumors require surgery?

No. Tumors which secrete high amounts of the hormone prolactin usually respond to medical therapy so that surgery is not required. Small non-secretory tumors, less than one centimeter (termed a "microadenoma"), can sometimes be followed with serial MRIs to monitor for progressive enlargement before proceeding to surgery.

How should I choose a surgeon for my pituitary operation?

It has been shown that the success of surgery is dependent on the amount of experience the surgeon has at performing pituitary operations. Surgeons with the most experience generally have the highest rates of cure, meaning complete tumor removal. In addition, the rate of complications is lowest among experienced pituitary surgeons. Surgeons at major pituitary centers, such as the Massachusetts General Hospital Neuroendocrine Clinical Center, operate on patients with pituitary tumors every week.

What are the risks of the surgery?

The most common risk is damage to the normal pituitary gland. For macroadenomas (>1cm) this happens between 5-10% of the time when the operation is performed by an expert pituitary surgeon. This means that new hormone replacement might be required after the surgery, possibly including thyroid hormone, cortisol, growth hormone, estrogen or testosterone. Damage to the posterior, or back portion, of the pituitary gland may produce a condition known as diabetes insipidus, which will lead to frequent urination and excessive thirst, since the kidneys will no longer adequately concentrate the urine. This can be controlled with a nasal spray or pill form of a medication called DDAVP. Permanent diabetes insipidus occurs 1-2% of the time after pituitary surgery.

Are there other more serious complications?

Yes, but they are very rare. There is a very small chance of damaging the carotid arteries which are located on either side of the pituitary. This is a potentially devastating complication which could lead to stroke or death. It occurs very infrequently, when the operation is performed by an expert pituitary surgeon, with an incidence of less than 1/1000 cases. There could also be post-operative bleeding into any residual tumor or into the sella, which could lead to worsening pressure on the optic nerves or chiasm and possible visual loss. This is also a very rare complication, but might require re-operation to remove the blood clot. A spinal fluid leak sometimes occurs because pituitary tumors are separated from the spinal fluid which bathes the brain by a very thin membrane. In order to prevent a spinal fluid leak, the tumor bed is packed with a small piece of abdominal fat taken from a tiny incision made in the abdominal skin. Despite this, spinal fluid leaks occur with an incidence of about 1%. If this happens, there is a risk of infection, called meningitis. If a spinal fluid leak occurs it may require a second operation to patch the leak. The risk of all complications is higher with less experienced surgeons.

How long does the operation take?

The procedure itself usually takes about three hours. Patients go to the recovery room for two to three hours after the surgery and are then admitted to the hospital floor. There is no need to stay in an Intensive Care Unit. Most patients are discharged from the hospital in just one or two days. How will I feel after the surgery? You will have a sinus headache and nasal congestion. This will gradually improve over a few weeks. You can take decongestants which will help these symptoms. It is common to feel fatigued for two-three weeks after the surgery and this gradually improves.

How long will I be out of work?

That depends on what you do. The average would be about two weeks.

How will we know if the entire tumor has been removed?

For hormone secreting tumors (Cushing's, acromegaly, prolactinomas), blood and urine tests in the days or weeks following surgery provide the answer. For non-secreting tumors, pituitary MRI scans are used to determine this. Some centers, such as Massachusetts General Hospital, have a special MRI machine in the operating room, which is used in patients with large tumors, to follow the progress of tumor removal during the operation. Because the surgeon works only from the inside of the tumor, it is sometimes difficult to tell how much tumor remains during the procedure. The intra-operative MRI helps us to see whether there is more to be removed. Tumor in the cavernous sinus can rarely be removed even with the use of the MRI (as noted in Question 4). A postoperative MRI is obtained about six weeks after the surgery. This helps determine whether further therapy is required. If the tumor is a hormone secreting adenoma (prolactinoma, Cushing's disease or acromegaly), the endocrinologist will follow your hormone levels postoperatively to determine whether you are cured.

What is the chance of being cured?

It depends upon the type, size and location of the tumor and the expertise of the surgeon. Patients with Cushing's disease usually have small tumors (microadenomas) and are surgically cured about 90% of the time based on data published by expert pituitary surgeons. Patients with acromegaly often have larger, more invasive tumors which are harder to cure surgically. The success rate with growth-hormone secreting macroadenomas is about 60% in the best surgical series. Non-secreting tumors are often macroadenomas as well. Whether a macroadenoma can by completely removed depends upon whether it has grown into the cavernous sinus, bone, or elsewhere. If it has not grown into these areas, a surgical cure can often be achieved. If tumor has grown into an area where it is not possible or safe for the surgeon to operate, it may not be surgically curable. However, such tumors can often be de-bulked away from the optic nerves and chiasm, in order to protect vision. Radiation therapy may be required to control further growth.

What if tumor is left behind after an attempt at surgical removal. Is radiation always required?

If there is a substantial amount of a non-secretory tumor remaining after a transsphenoidal operation, radiation therapy can be used to halt further growth of the residual tumor. There are now a number of different forms of radiation treatment available for pituitary tumors. If only a small amount of tumor remains, it can often be followed with serial MRIs and further therapy deferred until there are signs of regrowth, which may not occur for years. If there is residual tumor after surgery for acromegaly, Cushing's disease, or prolactinomas, medical treatments are available to control the excess hormone secretion. These medications, which are typically given under the supervision of an endocrinologist, can sometimes be used instead of, or in addition to, radiation therapy.

Who will take care of me in the hospital?

At a major pituitary center, such the Neuroendocrine Clinical Center at Massachusetts General Hospital, you will be managed by a team of physicians. This includes your neurosurgeon, a staff neuroendocrinologist and the residents and fellows who work with them. The team will follow you until you can be returned to the care of your local endocrinologist and primary care physician. Endocrine follow-up is very important, to determine whether replacement of any of the hormones controlled by the pituitary (cortisol, thyroxine, estrogen/testosterone, growth hormone or vasopressin) is needed. Article borrowed from National Endocrine and Metabolic Diseases Information Services RECENT NEWS C

Continue reading


Travel Assistance


The cost of treating Acromegaly doesn't only involve the medical costs, we also need to consider travel costs, including hotel stays, flights to and from appointments, and additional extra and unexpected costs that are travel related. Some patients are restricted to which medical team they choose because travel costs are unaffordable. The majority of these patients do not live near a larger metropolitan area which limits which doctors they have at their disposal, leaving them to choose from doctors who have never worked with, let alone heard of, Acromegaly. In order to get the best care possible, many patients travel outside of their hometown, or even their home state, to get the best care possible. For some patients,the travel resources below may help get better care by getting travel assitance.

Miracle Flights

Miracle Flights has the cure for distance. Miracle Flights is a nonprofit organization that helps sick children fly to distant medical care. Since 1985, Miracle Flights has established itself as the nation’s leading nonprofit health and welfare flight organization, providing financial assistance for flights so that those with serious illnesses may receive life-altering, life-saving medical treatment and valuable second opinions from experts and specialists throughout the United States. Flights are coordinated through commercial airlines at no cost to families and as many times as necessary: Whether it's a one-time flight to obtain a proper diagnosis or several flights for ongoing treatment, there is no limit to the number of times Miracle Flights will fly patients, free of charge, to receive the medical care they require. Through the support of generous community partners and individual donors, Miracle Flights gives hope to families that their children and loved ones may live longer, healthier lives. For additional information, please visit

To request a flight, please call 800-359-1711 and speak with a Flight Specialists to see if you meet the income eligibility requirements. Flights can be requested 60 days prior to their appointment, but no later than 14 days before it. 

Continue reading

Laboratory Information

Laboratory Information

Surgery might seem frightening, but inaction has other risks

Acromegaly will cause visible deformities including changes in bone structure and soft tissue. Ultimately, there will be obvious changes in facial appearance (under or overbite, nose, forehead) and enlargement of the hands and feet. If the tumor starts to release excess growth hormone during adolescence or before, a person may also exhibit symptoms of gigantism. You may also suffer sleep apnea, and carpal tunnel syndrome.

Because of the serious changes, treatment is essential!

Chart for Gauging Your IGF-1

Continue reading

Acromegaly does not define us. We do not let our diagnosis hold us back from living a full and enriched life. Some have found passion, purpose, and inspiration through their diagnosis. These people bring inspiration, and we call this our "Faces of Hope".

Say hello.